Progyny (PGNY) Tops Q2 EPS by 5c

Progyny (NASDAQ: PGNY) reported Q2 EPS of $0.15, $0.05 better than the analyst estimate of $0.10. Revenue for the quarter came in at $279.4 million versus the consensus estimate of $261.91 million.

For earnings history and earnings-related data on Progyny (PGNY) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist
• UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results